spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  cancer vaccine 

 HSMN NewsFeed - 30 May 2024
US FDA Awards Supplemental Orphan Drug Designation to Survaxm to Now Include Treatment of Malignant Glioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Apr 2023
Geneos Therapeutics Secures $5 Million in Series A3 Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Oct 2022
Geneos Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Sep 2022
Nouscom Strengthens Leadership Team with the Appointments of Sven Gogov, MD, as Chief Medical Officer and Maria Arce-Tomas, PhD, as VP, Head of Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Mar 2021
VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Dec 2020
AIVITA Biomedical Closes $25 Million Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Dec 2020
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jun 2020
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Jun 2020
FDA Clears IND for iNKT Cells to Treat COVID-19 Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Mar 2020
Agenus Receives Fast Track Designation for Balstilimab & Zalifrelimab in Advanced Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Mar 2020
Alopexx Oncology Announces Licensing Agreement with Beijing Shenogen Pharma Group for Development and Commercialization of Novel Immunocytokine for the Treatment of B-Cell Lymphomas in China/Asia
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 7 Feb 2020
Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Dec 2019
Anixa Biosciences Announces Commercial Launch of Cchek(TM) Prostate Cancer Confirmatory Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 22 Nov 2019
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study
Diagnostics Urology Oncology
 HSMN NewsFeed - 28 Oct 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Oct 2019
Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts
Diagnostics Oncology Personnel
 HSMN NewsFeed - 2 Sep 2019
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Biopharmaceuticals Drug Delivery Oncology Acquisitions
 HSMN NewsFeed - 17 Jul 2019
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 17 Jun 2019
Valo Therapeutics Appoints Michael Stein as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2019
Inovio Appoints Global Commercial Leader to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Oct 2018
EpiVax Oncology Appoints Dominique Bridon as Chief Technology Officer and Dan Adams to the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jul 2018
MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Jun 2018
Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Jan 2018
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Dec 2017
Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Nov 2017
NewLink Genetics Appoints Eugene Kennedy, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Sep 2017
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 6 Sep 2017
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Apr 2017
Asterias Announces Publication of Positive Phase 2 Data on AST-VAC1 for the Treatment of Acute Myeloid Leukemia (AML) in 'Cancer'
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 2 Nov 2016
Turnstone Biologics Raises $41.4 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 17 May 2016
Nouscom Concludes Successful Series A Financing of EUR 12 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 13 Apr 2016
Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2016
TapImmune Granted Fast Track Designation by U.S. Food & Drug Administration for its Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Dec 2015
Dr. Elizabeth Nabel Joins Moderna Therapeutics’ Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2015
Vaccinogen Promotes Peter Morsing, Ph.D. to Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Oct 2015
Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 19 Oct 2015
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Sep 2015
POZEN Appoints James P. Tursi, M.D. Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel
 HSMN NewsFeed - 24 Jun 2015
ViraTherapeutics Raises €3.6 Million in the First Closing of a Series A Financing Round to Advance its Novel Oncolytic Virus Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel
 HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 18 Mar 2015
Innocoll AG Appoints James Tursi, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 23 Dec 2014
Personalized Cancer Vaccine Moves to Phase IIb Trial at Leading U.S. Cancer Hospitals
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS
 HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2014
Vaccinogen Completes Initial Closing of an $80 Million Financing
Biopharmaceuticlas Oncology Venture Capital
 HSMN NewsFeed - 9 Jun 2014
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Mar 2014
Heat Biologics, Inc. Appoints Taylor H. Schreiber, M.D., PH.D. as Vice President of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Feb 2014
Ichor Enters into an Agreement with Pfizer to Develop Electroporation Devices for Use in Therapeutic Cancer Vaccine Regimens
Biopharmaceuticals Drug Delivery Oncology Licensing
 HSMN NewsFeed - 9 Jan 2014
Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Dec 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Nov 2013
Agalimmune Ltd Founded to Develop Immunotherapeutics for Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Sep 2013
Heat Biologics Appoints Louis C. Bock to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 May 2013
FANG(TM) Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 31 Jan 2013
Aduro Announces $6.5 Million Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Jan 2013
Gradalis, Inc. Closes $24 Million in Series B Financing to Advance Late-Stage Trials of FANG(TM) Personalized Cancer Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Dec 2012
ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Oct 2012
Sirona Biochem Names Neil Belenkie as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2012
Polynoma Announces Appointment of New Members to Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2012
Biovest Advances Process Seeking European Marketing Approval for BiovaxID(TM) Personalized Lymphoma Vaccine
Biopharmaceuticals Oncology Personalized Medicine
 HSMN NewsFeed - 9 Jul 2012
PsiOxus Therapeutics Secures £22 Million ($34 Million) in Series B Financing to Drive Clinical Development for Oncolytic Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 May 2012
Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Mar 2012
Bellicum Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel™
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2011
Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Sep 2011
Immunovaccine Announces Appointment of John Trizzino as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Aug 2011
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2011
Aduro BioTech Completes $19.25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Mar 2011
RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2011
Pro-Pharmaceuticals Names Peter G. Traber, M.D., Former GlaxoSmithKline Chief Medical Officer & President Emeritus of Baylor College of Medicine, President & Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2010
Bavarian Nordic Receives Special Protocol Assessment Agreement From the FDA for Phase 3 Trial of PROSTVAC(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Nov 2010
Accentia Biopharmaceuticals Announces Strategic Agreement with Baxter
Biopharmaceuticals
 HSMN NewsFeed - 12 Oct 2010
Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Oct 2010
Phase III Data Showing Improved Survival With Jevtana(R) (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2010
Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2010
Accentia Files Plan of Reorganization
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Mar 2010
Rib-X Appoints Mark Leuchtenberger as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2010
Geron Highlights Product Launch from Collaboration with Corning - the Synthemax Surface for Scalable Growth of Human Embryonic Stem Cells
Regenerative Medicine
 HSMN NewsFeed - 23 Feb 2010
TopoTarget Announces New CEO to Prepare Commercialisation of Belinostat
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2010
IRX Therapeutics Appoints Neil L. Berinstein Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2010
GeoVax Labs, Inc. Announces Appointment of Mark J. Newman, Ph.D. as Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2009
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Sep 2009
CSL Biotherapies Reaches Agreement with Merck & Co. on Rights to Market and Distribute Afluria(R) in the U.S.
Biopharmaceuticals Distribution
 HSMN NewsFeed - 9 Sep 2009
FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKline's Candidate Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Aug 2009
Geron Comments on FDA Hold on Spinal Cord Injury Trial
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Aug 2009
Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics' Oncophage(R) Cancer Vaccine in Newly Diagnosed Glioma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Jun 2009
Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jun 2009
Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Jun 2009
ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2009
PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2009
Bavarian Nordic Updates on Phase I/II Studies With Breast Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jan 2009
Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Regenerative Medicine Neurosurgery FDA
 HSMN NewsFeed - 13 Jan 2009
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2008
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Nov 2008
GARDASIL®, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2008
FDA Grants Permission For Export of Antigenics' Oncophage(R) to Russia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Sep 2008
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Sep 2008
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Jul 2008
Advaxis Incorporated Receives List of Questions from the U.S. Food and Drug Administration
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Jun 2008
GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Jun 2008
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Jun 2008
Biovest Reports Blinded Results for Phase 3 Study Evaluating Anti-Cancer Vaccine, BiovaxID(R), which Shows 100% Difference in Disease-Free Survival at 36 Months in the Comparative Arms
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Jun 2008
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 May 2008
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 May 2008
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
Biopharmaceuticals
 HSMN NewsFeed - 17 Apr 2008
Accentia Announces that After Reviewing Unblinded Results, Independent DMC Recommends Presenting Data on BiovaxID(R) to FDA and Worldwide Regulatory Agencies in Order to Seek Marketing Approvals for Follicular Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2008
Biovest Reports that Independent Data Monitoring Committee Recommends Unblinding of Phase 3 Clinical Results for its Anti-Cancer Vaccine, BiovaxID(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2008
Low HER2 Expressing Breast Cancer Patients Respond Preferentially to Apthera's NeuVax(TM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Apr 2008
Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
Supplemental Application for GARDASIL(R), Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Feb 2008
Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Jan 2008
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Dec 2007
GlaxoSmithKline Receives FDA 'Complete Response' Letter for Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Dec 2007
AVAX Technologies Appoints Dr. Francois Martelet as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2007
AVAX Technologies announces the initiation of its Phase III Registration trial of M-Vax(R) in Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Oct 2007
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Oct 2007
Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Oct 2007
Accentia Announces Investigational New Drug Application for Revimmune Usage in a Pivotal Phase 3 Study of Refractory Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Accentia Biopharmaceuticals Announces Completion of Enrollment in Fast-Tracked Pivotal Phase 3 Clinical Trial of SinuNase for Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Sep 2007
Bavarian Nordic - Strengthens Commercial Focus; Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2007
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2007
Geron Scientists and Collaborators Demonstrate Human Embryonic Stem Cell-Derived Cardiomyocytes Improve Heart Function When Transplanted After Myocardial Infarction
Regenerative Medicine Cardiology
 HSMN NewsFeed - 15 Aug 2007
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 3 Aug 2007
Semafore Pharmaceuticals Names Veteran Life Sciences Executive Edward L. Jacobs as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2007
Antigenics Provides Update on Filing for Approval of Oncophage(R) in Russia for the Treatment of Intermediate-Risk Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Jul 2007
Accentia Biopharmaceuticals Files Pre-Investigational New Drug (IND) Application with FDA for Pivotal Phase 3 Clinical Trial of Revimmune for Refractory Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Jul 2007
GSK's Cervical Cancer Candidate Vaccine Cervarix(TM) Receives Positive Opinion in Europe for Prevention of Cervical Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Jul 2007
Agensys Raises $41 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jun 2007
Largest Cervical Cancer Vaccine Efficacy Trial Shows CERVARIX(R) Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jun 2007
CERVARIX(R), the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jun 2007
Biovest to File for Accelerated Conditional Approval of BiovaxID
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 May 2007
Progenics and Wyeth Announce FDA Has Accepted For Filing the New Drug Application for Subcutaneous Methylnaltrexone
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2007
Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 21 May 2007
Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 May 2007
Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2007
Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2007
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 17 Apr 2007
CERVARIX(R), GSK Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2007
Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Apr 2007
Northwest Biotherapeutics Files for Authorization for Use of DCVax(R)-Brain for Commercialization in Switzerland
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Apr 2007
Advaxis Completes Dosing and Enrollment of Third Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial
Biopharmacetuicals Oncology
 HSMN NewsFeed - 16 Apr 2007
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Mar 2007
Progenics and Wyeth Announce Submission of New Drug Application for the Subcutaneous Formulation of Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients Receiving Palliative Care
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 29 Mar 2007
GlaxoSmithKline Submits Biologics License Application to U.S. Food and Drug Administration for CERVARIX(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2007
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Feb 2007
First patient enrolled in Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jan 2007
GlaxoSmithKline Initiates Head-to-Head Study of Cervical Cancer Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2007
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
Regenerative Medicine Neurology
 HSMN NewsFeed - 8 Jan 2007
Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Jan 2007
Progenics Pharmaceuticals Expands Senior Management Team and Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2007
Medistem Laboratories Appoints Thomas Ichim to Be Chief of Scientific Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 2 Jan 2007
Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer now open for patient enrollment
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Dec 2006
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2006
Wyeth and Progenics Initiate Second Global Phase 3 Trial of Intravenous Methylnaltrexone to Treat Post-operative Ileus
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2006
Advaxis Names Thomas A. Moore to Serve as CEO and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2006
Progress Reported Toward Development of a Breast Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Dec 2006
HER2/neu Vaccine Results Spurs Phase III Planning by Apthera, Inc.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2006
Coley Pharmaceutical Amends Strategic Alliance License Agreement With GlaxoSmithKline for VaxImmune(TM) Vaccine Adjuvant
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 Nov 2006
Northwest Biotherapeutics Receives Institutional Review Board Approval to Accrue Patients in Phase II Brain Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Nov 2006
Merck Launches National Advertising Campaign for GARDASIL(R), Merck's New Cervical Cancer Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2006
Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2007
Devices Biopharmaceuticals Cardiology Oncology Neurology
 HSMN NewsFeed - 6 Nov 2006
Accentia Biopharmaceuticals Commences Fast-Tracked Phase 3 Clinical Trial of SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2006
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Nov 2006
Merck's Cervical Cancer Vaccine, GARDASIL(R), Added to the CDC Vaccines for Children Contract
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2006
Mathematical Model Based on Clinical Findings From Cervarix(TM), GSK's Cervical Cancer Candidate Vaccine, Suggests Vaccination Could Reduce Cervical Cancers by up to 80%
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Oct 2006
New Landmark Study Shows the Use of a BiovaxID Formulation Improves Disease Free survival in 80% of Patients Whose Cancer has Relapsed after Chemotherapy Administered With or Without Rituxan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Oct 2006
Geron Appoints Alan Colowick as President, Oncology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2006
AVAX Technologies Announces Special Protocol Assessment Agreement with FDA for a Phase III Clinical Trial of M-Vax in Metastatic Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Oct 2006
ARIAD Grants Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Oct 2006
Bellicum Pharmaceuticals Announces Commercial Licensing of ARIAD's ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Oct 2006
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Sep 2006
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Sep 2006
Carrington Subsidiary to Develop Needle-less Delivery of Cervical Cancer Vaccine With the National Cancer Institute (NCI)
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Sep 2006
Progenics and Wyeth Initiate Global Phase 3 Clinical Program of Intravenous Methylnaltrexone to Treat Post-Operative Ileus
Biopharmaceuticals
 HSMN NewsFeed - 14 Sep 2006
Hyam I. Levitsky, MD, Joins Antigenics' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2006
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Jul 2006
FDA Grants Intracel Special Protocol Assessment (SPA) for Confirmatory, Pivotal Phase III Study of OncoVAX(R) Colon Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Jul 2006
Wyeth and Progenics Announce Methylnaltrexone Receives FDA Fast Track Designation for Treatment of Postoperative Ileus
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jul 2006
Latest Data Confirm GlaxoSmithKline's Proprietary Adjuvant System For Cervarix(TM) Induces a Stronger and More Sustained Immune Response Than a Conventional Adjuvant Formulation
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jul 2006
Antigenics Announces Expansion of Its License and Supply Agreement With GlaxoSmithKline Biologicals for QS-21 Stimulon(R) Adjuvant
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jun 2006
GlaxoSmithKline Applauds ACIP for New Guidance on Use of HPV Vaccine to Protect Girls and Women Against Cervical Cancer
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2006
Merck's New Cervical Cancer Vaccine, GARDASIL(R), Unanimously Recommended by CDC Advisory Panel for Vaccination of Girls and Women 11 to 26 Years
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2006
Chemokine Therapeutics names Guy Ely, MD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2006
YM Biosciences announces independent Data Safety Monitoring Board recommends tesmilifene pivotal trial continue as planned
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2006
Association Between Molecular Remission and Disease-Free Survival in Non-Hodgkins Lymphoma at Over Nine Years Follow-Up To Be Presented
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2006
Northwest Biotherapeutics Updates Brain Cancer Clinical Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2006
Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2006
FDA Advisory Committee Votes Unanimously That Clinical Data Support the Efficacy and Safety of GARDASIL(R), Merck's Investigational Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 May 2006
FDA Gives Permission to Use Very Sensitive Molecular Evidence of Cancer in BiovaxID Pivotal Phase 3 Clinical Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 May 2006
Advaxis Continues Advancement of Two Listeria Vaccines Targeting Cancers Affecting Women
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 May 2006
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 May 2006
Biovest's AutovaxID(TM) Cleared for Commercial Sale
Biopharmaceuticals Devices FDA
 HSMN NewsFeed - 9 May 2006
YM Biosciences completes acquisition of Eximias
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 May 2006
Biovest International Announces Addition to Senior Management Team
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 301

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 301 additional stories matching:
cancer vaccine
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.